HUT50442A - Process for producing pharmaceutical composition comprising sour dock extract as active ingredient
- Google Patents
Process for producing pharmaceutical composition comprising sour dock extract as active ingredient
Info
Publication number
HUT50442A
HUT50442AHU87119AHU11987AHUT50442AHU T50442 AHUT50442 AHU T50442AHU 87119 AHU87119 AHU 87119AHU 11987 AHU11987 AHU 11987AHU T50442 AHUT50442 AHU T50442A
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Janosne LaurinyeczfiledCriticalJanosne Laurinyecz
Priority to HU87119ApriorityCriticalpatent/HU200420B/en
Publication of HUT50442ApublicationCriticalpatent/HUT50442A/en
Publication of HU200420BpublicationCriticalpatent/HU200420B/en
Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
Y02—TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
Y02A—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE
Y02A50/00—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE in human health protection, e.g. against extreme weather
Y02A50/30—Against vector-borne diseases, e.g. mosquito-borne, fly-borne, tick-borne or waterborne diseases whose impact is exacerbated by climate change
Landscapes
Medicinal Preparation
(AREA)
Medicines Containing Material From Animals Or Micro-Organisms
(AREA)
Medicines Containing Plant Substances
(AREA)
Abstract
A medicinal prepn. for the treatment of salmonellosis contains a concentrate obtd. from an aq. or alcoholic or aq. alcoholic extract of seeds of Licmex Acetosa.
HU87119A1987-01-151987-01-15Process for producing pharmaceutical compositions containing extract of ruemx speciosus as active component
HU200420B
(en)
Pharmaceutical compositions containing a derivative of 3-hydroxy-butanoic acid chosen among oligomers of this acid and among esters of this acid or of these oligomers with 1,3-butane-diol
Pharmaceutical formulations containing melphalan or melphalan hydrochloride, as well as melphalan and melphalan hydro-chloride and processes for preparing them
4-fluoro-2-//(4-methoxy-2-pyridyl)methyl/sulfinyl/ -1h - benzimidazole, process for its production and a pharmaceutical comprising said compound as an active component
Use of oenotheine B for the manufacture of a medicament for the treatment of disorders related to hyperandrogenism, pharmaceutical compositions containing oenotheine B and a process for its preparation from epilobium parviflorum.